South Korea's Biostar Stem Cell Research Institute, jointly operated by Nature Cell and Rbio, today announced that Trinity Clinic Fukuoka, a partner hospital in Japan, received approval for the application of regenerative medicine in Alzheimer's disease a
Bristol-Myers Squibb has begun a research collaboration with a group stem cell experts from Harvard University into fibrotic diseases, including fibrosis of the liver and heart.
CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take a calculated risk on Prexton Therapeutics and its sole candidate for Parkinson’s.